Results for tag: "Otezla"

Otezla is a prescription drug used to treat psoriasis and psoriatic arthritis. It is a small molecule inhibitor of phosphodiesterase 4 (PDE4), an enzyme involved in the regulation of inflammation. Otezla is the only approved oral PDE4 inhibitor for the treatment of psoriasis and psoriatic arthritis. It is taken as a pill once or twice a day and works by reducing inflammation in the skin and joints. Otezla is part of a larger market of dermatological drugs, which includes topical creams, ointments, and injections. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and rosacea. Other drugs in this market include topical corticosteroids, topical retinoids, and topical calcineurin inhibitors. Some companies in the dermatological drug market include AbbVie, Amgen, Celgene, Janssen, and Novartis. Show Less Read more